GALT - Galectin Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GALT is currently covered by 1 analysts with an average price target of $7.65. This is a potential upside of $4.83 (171.28%) from yesterday's end of day stock price of $2.82.

Galectin Therapeutics's activity chart (see below) currently has 6 price targets and 10 ratings on display. The stock rating distribution of GALT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.83% with an average time for these price targets to be met of 135.67 days.

Highest price target for GALT is $11, Lowest price target is $11, average price target is $7.65.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 15-Nov-2024. First documented stock forecast 28-Mar-2016.

Best performing analysts who are covering GALT - Galectin Therapeutics:

Yasmeen Rahimi Vernon Bernardino Ed Arce

Currently out of the existing stock ratings of GALT, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$8.2 (292.86%)

$11

5 days ago
(15-Nov-2024)

1/8 (12.5%)

$8.2 (292.86%)

168

Buy

$8

$6.29 (367.84%)

$3

6 years 10 months 17 days ago
(04-Jan-2018)

3/3 (100%)

$3.74 (87.79%)

140

Buy

$5

$3.29 (192.40%)

$2

7 years 1 months 15 days ago
(06-Oct-2017)

3/3 (100%)

$2.56 (104.92%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GALT (Galectin Therapeutics) average time for price targets to be met?

On average it took 135.67 days on average for the stock forecasts to be realized with a an average price target met ratio 70.83

Which analyst has the current highest performing score on GALT (Galectin Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the current lower performing score on GALT (Galectin Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on GALT (Galectin Therapeutics)?

Yasmeen Rahimi works at PIPER SANDLER and has 4 price targets and 4 ratings on GALT

Which analyst is the currently most bullish on GALT (Galectin Therapeutics)?

Ed Arce with highest potential upside - $8.2

Which analyst is the currently most reserved on GALT (Galectin Therapeutics)?

Vernon Bernardino with lowest potential downside - $3.29

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?